Pharmacological DNMT1 deficiency promotes selective macrophage activation by blocking PPAR promoter DNA methylation, and DNMT1-deficient mice show improved M2 differentiation, reduced macrophage inflammation, and ameliorated obesity-induced inflammation and IR (83). The gene discussed is DNMT1; the disease is obesity due to melanocortin 4 receptor deficiency.